Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers
© International Society of Travel Medicine 2023. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissionsoup.com..
BACKGROUND: Artemisinin-based combination therapy (ACT) for the treatment of malaria is highly effective, well tolerated and safe. Episodes of delayed haemolysis occur in up to 57.9% of patients with severe malaria treated with intravenous artesunate, mainly caused by 'pitting' of infected red blood cells in the spleen and the delayed loss of these once-infected RBCs (oiRBCs). Several reports indicate that post-treatment haemolysis (PTH) also occurs in uncomplicated malaria treated with oral ACT, calling for systematic investigation.
METHODS: A prospective observational study to identify the incidence of PTH after oral ACT, defined as increased lactate dehydrogenase activity and low haptoglobin level on Day 14 after treatment. Patients were enrolled at two study centres in Germany and Italy. Study visits took place on Days 1, 3, 7, 14 and 28. Laboratory investigations included extended clinical routine laboratory tests, quantitative PfHRP2, anti-RBC antibodies and oiRBCs. The state of semi-immunity to malaria was assessed from childhood and ongoing exposure to Plasmodium spp. as per patient history.
RESULTS: A total of 134 patients with uncomplicated malaria and 3-day ACT treatment were recruited. Thirty-seven (37.4%) of 99 evaluable patients with Pf and none of 9 patients with non-Pf malaria exhibited PTH on d14. Patients with PTH had higher initial parasitaemia, higher oiRBC counts on d3 and a 10-fold decrease in oiRBCs between d7 and d14 compared with patients without PTH. In patients with PTH, loss of haemoglobin was 4-fold greater in non-Africans than in Africans (-1.3 vs -0.3 g/dl). Semi-immune African patients with PTH showed markedly increased erythropoiesis on d14 compared with not semi-immune African and non-African patients with PTH.
CONCLUSIONS: PTH is common in patients with uncomplicated malaria and oral ACT. While the observed loss of haemoglobin will often not be clinically relevant, it could aggravate pre-existing anaemia, warranting follow-up examinations in populations at risk.
Errataetall: |
CommentIn: J Travel Med. 2023 May 18;30(3):. - PMID 36799808 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Journal of travel medicine - 30(2023), 3 vom: 18. Mai |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kurth, Florian [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 22.05.2023 Date Revised 22.05.2023 published: Print CommentIn: J Travel Med. 2023 May 18;30(3):. - PMID 36799808 Citation Status MEDLINE |
---|
doi: |
10.1093/jtm/taad001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351221026 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM351221026 | ||
003 | DE-627 | ||
005 | 20231226050835.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/jtm/taad001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1170.xml |
035 | |a (DE-627)NLM351221026 | ||
035 | |a (NLM)36611010 | ||
035 | |a (PII)taad001 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kurth, Florian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.05.2023 | ||
500 | |a Date Revised 22.05.2023 | ||
500 | |a published: Print | ||
500 | |a CommentIn: J Travel Med. 2023 May 18;30(3):. - PMID 36799808 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © International Society of Travel Medicine 2023. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissionsoup.com. | ||
520 | |a BACKGROUND: Artemisinin-based combination therapy (ACT) for the treatment of malaria is highly effective, well tolerated and safe. Episodes of delayed haemolysis occur in up to 57.9% of patients with severe malaria treated with intravenous artesunate, mainly caused by 'pitting' of infected red blood cells in the spleen and the delayed loss of these once-infected RBCs (oiRBCs). Several reports indicate that post-treatment haemolysis (PTH) also occurs in uncomplicated malaria treated with oral ACT, calling for systematic investigation | ||
520 | |a METHODS: A prospective observational study to identify the incidence of PTH after oral ACT, defined as increased lactate dehydrogenase activity and low haptoglobin level on Day 14 after treatment. Patients were enrolled at two study centres in Germany and Italy. Study visits took place on Days 1, 3, 7, 14 and 28. Laboratory investigations included extended clinical routine laboratory tests, quantitative PfHRP2, anti-RBC antibodies and oiRBCs. The state of semi-immunity to malaria was assessed from childhood and ongoing exposure to Plasmodium spp. as per patient history | ||
520 | |a RESULTS: A total of 134 patients with uncomplicated malaria and 3-day ACT treatment were recruited. Thirty-seven (37.4%) of 99 evaluable patients with Pf and none of 9 patients with non-Pf malaria exhibited PTH on d14. Patients with PTH had higher initial parasitaemia, higher oiRBC counts on d3 and a 10-fold decrease in oiRBCs between d7 and d14 compared with patients without PTH. In patients with PTH, loss of haemoglobin was 4-fold greater in non-Africans than in Africans (-1.3 vs -0.3 g/dl). Semi-immune African patients with PTH showed markedly increased erythropoiesis on d14 compared with not semi-immune African and non-African patients with PTH | ||
520 | |a CONCLUSIONS: PTH is common in patients with uncomplicated malaria and oral ACT. While the observed loss of haemoglobin will often not be clinically relevant, it could aggravate pre-existing anaemia, warranting follow-up examinations in populations at risk | ||
650 | 4 | |a Observational Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Artemisinin combination therapy | |
650 | 4 | |a Post-treatment haemolysis | |
650 | 4 | |a malaria | |
650 | 4 | |a once-infected red blood cells | |
650 | 4 | |a uncomplicated malaria | |
650 | 7 | |a Antimalarials |2 NLM | |
650 | 7 | |a Artemisinins |2 NLM | |
650 | 7 | |a Hemoglobins |2 NLM | |
700 | 1 | |a Tober-Lau, Pinkus |e verfasserin |4 aut | |
700 | 1 | |a Lingscheid, Tilman |e verfasserin |4 aut | |
700 | 1 | |a Bardtke, Lara |e verfasserin |4 aut | |
700 | 1 | |a Kim, Johanna |e verfasserin |4 aut | |
700 | 1 | |a Angheben, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Gobbi, Federico G |e verfasserin |4 aut | |
700 | 1 | |a Mbavu, Lena |e verfasserin |4 aut | |
700 | 1 | |a Stegemann, Miriam S |e verfasserin |4 aut | |
700 | 1 | |a Heim, Katrin M |e verfasserin |4 aut | |
700 | 1 | |a Pfäfflin, Frieder |e verfasserin |4 aut | |
700 | 1 | |a Menner, Nikolai |e verfasserin |4 aut | |
700 | 1 | |a Schürmann, Mariana |e verfasserin |4 aut | |
700 | 1 | |a Mikolajewska, Agata |e verfasserin |4 aut | |
700 | 1 | |a Witzenrath, Martin |e verfasserin |4 aut | |
700 | 1 | |a Sander, Leif E |e verfasserin |4 aut | |
700 | 1 | |a Mayer, Beate |e verfasserin |4 aut | |
700 | 1 | |a Zoller, Thomas |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of travel medicine |d 1994 |g 30(2023), 3 vom: 18. Mai |w (DE-627)NLM093777884 |x 1708-8305 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2023 |g number:3 |g day:18 |g month:05 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/jtm/taad001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2023 |e 3 |b 18 |c 05 |